Welcome

Hello! Welcome to the Curriculum Vitae (Resume) section of Dr Vineet Govinda Gupta, MBBS, MD and DM Gold Medallist (AIIMS) Medical oncologist in Delhi, Gurgaon, Faridabad, Noida and NCR. Access ethical, scientific and world-class cancer care in the heart of Delhi NCR. You can read more about him and obtain contact details here. Educational resources for cancer patients can be accessed at various sections on this website by using the menu above. For a free E-consultation , click here.

Call/Whatsapp

Why do I call myself the “Best Medical Oncologist in Delhi NCR”?

While there are dozens of people who claim to be the best, I believe the word “best” can be distilled into two main ingredients:

• Qualification and experience: I have received my entire training from AIIMS New Delhi, the apex medical institute in the country and the mecca of health education and world-class medical treatment in India. In fact, I was a member of this institution for more than 12 years. In addition, I have been awarded honors including AIIMS Gold Medal for best Medical Oncologist. In addition, I have been the recipient of numerous national and international awards. Further, I have published numerous research papers in top medical journals in the country and abroad.
• Ethics and principles: While qualifications are important, I believe what is more important is the “why” and “how” of one’s practice. Cancer is a extremely difficult diagnosis for any person and cancer treatment is often misunderstood, difficult, exhausting and expensive. Throughout my practice, I have always followed the principle of viewing my patients from a standpoint of “how would I treat my own family member?” Accordingly, I ensure that I always offer the best, most scientific, ethical and available medical care to my patients.

My goal is not just to be a doctor, but a partner and friend in need to my patients.

Education and training

Dr Vineet has received his entire education and training from AIIMS, New Delhi, the most prestigious and apex medical institute of the country. He has spent more than 12 years at the institute.

M.B.B.S.: All India Institute of Medical Sciences, New Delhi

MD, Medicine: All India Institute of Medical Sciences, New Delhi

DM, Medical Oncology (Gold Medalist): All India Institute of Medical Sciences, New Delhi

European Certified Medical Oncologist: European Society for Medical Oncology, Lugano, Switzerland

Certified in Essentials of Palliative Care: Indian Association for Palliative Care

Skills and areas of Expertise in Oncology

Chemotherapy, Targeted therapy, Hormone therapy and Immunotherapy

Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation

Breast Cancer

Sarcomas including soft-tissue sarcomas, GIST, rhabdomyosarcoma, bone cancers including osteosarcoma, Ewing sarcoma/PNET and others

Thoracic malignancies including lung cancer and thymic cancer/thymoma

Gynaecological malignancies including gestational trophoblastic neoplasm, uterine, cervix, ovarian and vulvar cancer

Urological malignancies including kidney, bladder, prostate and testicular cancer

Gastrointestinal malignancies including colon, rectal, intestinal, stomach, gall bladder, liver, periampullary & pancreatic cancer and esophageal cancer

Endocrine cancers including neuroendocrine, thyroid and adrenal tumors

Head and neck cancers

Blood cancers including CML, CLL, AML, ALL, leukemias, lymphomas and multiple myeloma

Childhood cancers including Wilms Tumor, neuroblastoma, retinoblastoma, leukemias and medulloblastoma

Expertise in hematopoietic stem cell transplantation (HSCT) / Bone Marrow Transplantation (BMT)

I have been an integral part of the BMT program at IRCH, AIIMS New Delhi, the third-oldest BMT program in India, and have participated personally in more than a hundred transplants as part of the AIIMS team. I have also conducted research on HSCT/BMT (see list of publications below) and my research has been honored with a research grant by the government of india (see below). I have also personally conducted umbilical cord-blood transplants (UCBT).

Awards and Honors

• Shakuntala Jolly Gold Medal for best Medical Oncologist: AIIMS New Delhi
• European Society of Medical Oncology Examination: 96.7th percentile (among oncologists from the entire world)
• International Society of Pediatric Oncology Young Investigator Award (SIOP YIA) 2016 – SIOP 2016 Congress (October 2016, Ireland)
• Gold medal for 100th percentile score: University of New South Wales, Australia
• Best Medical Oncologist in Delhi NCR 2019: Healthcare awards 2019, New Delhi
• Recipient of numerous international grants and awards: Singapore, Czech republic, Ireland
• Certified in Essentials of Palliative Care: Indian Association for Palliative Care
• Recipient of multiple national scholarships
• All India postgraduation entrance examinations – Rank 10 (AIIMS).
• Recipient of CBSE merit scholarship for most meritorious students in the country during undergraduate training.

Research Experience

Proper treatment of cancer is based in science. The roots of scientific treatment is based on the principles of evidence based medicine, which ensures that only the most effective, scientific treatments are offered to patients with maximum benefit and minimum harm.

Accordingly, to be a good oncologist, one should have a strong research base in addition to being a clinician. Dr Gupta has numerous peer-reviewed publications in reputed Indian and International peer-reviewed journals. This includes the top 5 oncology journals in the world like JCO, NEJM and Lancet Oncology.

Some of his major publications are given below. You can click the links to read the full articles on their respective webpages:

Published, available online and in print

1. He, A. R., Boutatour, M., Gupta, V. G., Levesque, L., et al. (2023). Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised Phase 3 TOPAZ-1 study. Annals of Oncology, 34, S220. https://doi.org/10.1016/j.annonc.2023.09.1395.
2. Bhonde, M., Bose, C., Gupta, V. G., et al (2023). Identification of novel actionable SNVs using targeted comprehensive genome profiling in patients with sarcoma. Journal of Clinical Oncology, 41(16_suppl), e23520–e23520. https://doi.org/10.1200/JCO.2023.41.16_suppl.e23520
3. Suri, O., & Gupta, V. G. (2023). Lenvatinib can overcome immune resistance in head and neck cancer and achieve durable remission. South Asian Journal of Cancer, s-0043-1762939. https://doi.org/10.1055/s-0043-1762939
4. Gupta, V. (2022). Immunotherapy in recurrent head-and-neck cancer: Making the juice worth the squeeze. Cancer Research, Statistics, and Treatment, 5(4), 782. https://doi.org/10.4103/crst.crst_311_22
5. Mendiratta, M., Gupta, V.G., Rai, S., et al. (2022) Immune Reconstitution Following Hematopoietic Stem Cell Transplantation: A Study From AIIMS. ICKSH 2022
6. Patel, Amol, Gupta, V. G., et al. “Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India—A Survey Report.” South Asian Journal of Cancer, Feb. 2022, p. s-0041-1739187
7. Patel, A., Gupta, V. G., Biswas, B., Das, C. K., Batra, A., Ganguly, S., & Bhethanabhotla, S. (2021). Revisiting fulvestrant dosing in uncertain economic times. JCO Global Oncology, 7, 1–3. https://doi.org/10.1200/GO.20.00362
8. Patil, P., Gupta, V.G., Rangaraju, R., Abbas, W., Acharya, R., & Pandit, A. (2020). Survival outcomes with docetaxel, oxaliplatin, and fluorouracil regimen for the treatment of metastatic gastric adenocarcinoma: A single-center experience. Oncology Journal of India, 4(3), 110. https://doi.org/10.4103/oji.oji_8_20
9. Gupta, V. G., Rangaraju, R., Abbas, W., Bajpai, P., & Khetrapal, R. (2019). Immune checkpoint inhibitors: Real-world experience from india in advanced solid cancers that have progressed on chemotherapy.South Asian Journal of Cancer, 8(1), 65. doi:10.4103/sajc.sajc_167_18
10. Gupta, V. G., & Goel, V. (2018). Differences Between Chemotherapy-Resistant Disease and Inoperable Disease in Cervical Cancer Treated With Neoadjuvant Chemotherapy. Journal of Clinical Oncology. doi:10.1200/jco.2018.78.6632
11. Mendiratta, M., Gupta, V.G., Rai, S., et al. (2022) Immune Reconstitution Following Hematopoietic Stem Cell Transplantation: A Study From AIIMS. ISBMT 2022
12. Patel, A., & Gupta, V. G. (2018). Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. New England Journal of Medicine, 379(17), 1683-1685. doi:10.1056/nejmc1810514
13. Patel, A., &  Gupta, V. G. (2018). Adjuvant therapy in resectable gastric cancer—the CRITICS trial. The Lancet Oncology, 19(7). doi:10.1016/s1470-2045(18)30369-3
14. Naik, R. D., Batra, A., & Gupta, V. G. (2019). Palbociclib and Fulvestrant in Breast Cancer. New England Journal of Medicine, 380(8), 796-797. doi:10.1056/nejmc1816595
15. Srivastava, R. & Gupta, V. G., Dhawan, D., Geeta, K., & Bakhshi, S. (2018). Poor nutritional knowledge and food restrictions among families of children with cancer and their impact: A cross-sectional study of 700 families. Journal of Psychosocial Oncology, 36(5), 658-666. doi:10.1080/07347332.2018.1484840
16. Gupta, V. G., Rangaraju, R. R., Saha, R., & Bajpai, P. (2018). Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response. Journal of Gastrointestinal Cancer. doi:10.1007/s12029-018-0130-3
17. Gupta, V. G., & Bakhshi, S. (2018). Hyperbaric oxygen with cord blood transplants: Filling the donor gap. The National Medical Journal of India,30(5), 273-274. doi:10.4103/0970-258X.234396
18. Gupta, V. G., Gogia, A., Sharma, V., & Mallick, S. (2018). Lymphomatoid Granulomatosis with Isolated Cutaneous lesions: Prolonged remission after DA-EPOCH protocol. Turkish Journal of Hematology. doi:10.4274/tjh.2018.0020
19. Gupta, V.G., Gogia, A., et al (2017).Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural Killer/T cell lymphoma with local tumor invasiveness: A single-institution study from India. Indian Journal of Medical and Paediatric Oncology, 39(1), 67. doi:10.4103/ijmpo.ijmpo_60_17
20. Gupta, V. G., Gogia, A., Mehta, P., et al. (2016). 356P Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. Annals of Oncology, 27(Suppl_9). doi:10.1093/annonc/mdw586.025
21. Gupta, V.G., Srivastava R., Dhawan D., Geeta K, Bakhshi S. “Nutritional Ignorance And Restrictions Among Families Of Children With Cancer: A Cross-sectional Study Of 700 Families” – Oral presentation. SIOP 2016 Scientific Programme Index. (2016). Pediatric Blood & Cancer, 63. doi:10.1002/pbc.26233
22. Gupta, V. G., & Bakhshi, S. (2016). Pediatric Hematopoietic stem cell transplantation in India: Status, challenges and the way forward. The Indian Journal of Pediatrics, 84(1), 36–41. doi:10.1007/s12098-016-2253-5
23. Gupta, V. G., & Gogia, A. (2016). DDGP versus SMILE in NK/T-Cell Lymphoma–Letter. Clinical Cancer Research, 22(16), 4271-4271. doi:10.1158/1078-0432.ccr-16-1076
24. Gupta, V. G., Arora, B., Radhakrishnan, V., Banavali, S., & Bakhshi, S. (2015). Treatment rates of paediatric acute myeloid leukaemia: A view from three tertiary centres in India. British Journal of Haematology, 175(2), 346–347. doi:10.1111/bjh.13858
25. Patel, A., Gupta, V. G., Biswas, B., Das, C. K., Batra, A., Ganguly, S., & Bhethanabhotla, S. (2021).  Reply to D. O’Reilly et Al. JCO Global Oncology, no. 7, Apr. 2021, pp. 648–648. DOI.org (Crossref), doi:10.1200/GO.21.00077
26. Tiwari, A., Gupta, V. G., & Bakhshi, S. (2017). Newer medical therapies for metastatic soft tissue sarcoma. Expert Review of Anticancer Therapy, 17(3), 257-270. doi:10.1080/14737140.2017.1285229
27. Rastogi, S., & Gupta, V. (2017). Eribulin approval in advanced liposarcoma – successful drug or a weaker methodology? Indian Journal of Medical and Paediatric Oncology, 38(1), 2. doi:10.4103/0971-5851.203492
28. Patil, P., Gupta, V. G., Rangaraju, R., Abbas, W., & Bajpai, P. (2018). Prolonged survival with anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: A case series. Journal of Current Oncology, 1(2), 97. doi:10.4103/jco.jco_22_18
29. Batra, A., Patel, A., Gupta, V. G., et al. (2019). Oncotype DX: Where Does It Stand in India? Journal of Global Oncology, (5), 1-2. doi:10.1200/jgo.19.00151
30. Jain, A. K., Bhat, G., Gupta, V. G., & Goyal, H. (2021). Liquid biopsy. Indian Journal of Medical and Paediatric Oncology, 42(01), 077–079. https://doi.org/10.1055/s-0041-1729434
31. Patel, A., Tilak, T., Gupta, V., Batra, A., Mehta, P., Parikh, P., & Malhotra, H. (2019). Dynamics of sequencing of cyclin-dependent kinase inhibitors and cost expenditure analysis in the management of metastatic hormone-receptor positive, human epidermal growth factor 2-negative advancedbreast cancer. Indian Journal of Medical and Paediatric Oncology, 40(2), 311.
32. Abbas, W., Rao, R. R., Gupta, V. G., & Popli, S. (2019).Immunotherapy-induced interstitial lung disease: Cases report. South Asian Journal of Cancer, 8(2), 79. doi:10.4103/sajc.sajc_23_19
33. Das, C. K., Patel, A., Raj, A., Gupta, V. G., Mehta, P., Bhethanabhotla, S., Reddy, R., & Yadav, A. (2020). Anti-Her2neu directed therapy in advanced gall bladder cancer: A prospective, multicenter experience from India. Journal of Clinical Oncology, 38(15_suppl), e16682–e16682
34. Patel, A., Tannock, I. F., Srivastava, P., Biswas, B., Gupta, V. G., Batra, A., … Mehta, P. (2020). Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. JCO Global Oncology, (6), 382–386. doi: 10.1200/jgo.19.00341
35. Khilnani, G C; Gupta, V G; Singh, M B; Jain, N; Hadda, V; et al. Electrophysiological Abnormalities and Acquired Neuromusclular Weakness in Severe Sepsis and Its Impact on Outcome: A Prospective Study – American Journal of Respiratory and Critical Care Medicine; New York Vol. 191,  (2015): 1-2.
36. Selvakumar, V. P. P., Garg, S., Gupta, V.G., Goel, V., Rangaraju, R., (2019), Impact of Molecular Subtypes on Survival Outcomes in Breast Cancer : Indian perspective: 32nd NATCON IASO National Annual Conference 2018. Indian Journal of Surgical Oncology, 10, 99–141. doi:10.1007/s13193-019-00983-w
37. Abbas, W., Dixit, G., Rao, R., Gupta, V. G., & Popli, S. (2019). Immunotherapy-induced acute pulmonary thromboembolism: A case report. South Asian Journal of Cancer, 8(3), 172. doi:10.4103/sajc.sajc_25_19
38. Mittal, A., Sharma S., Gupta, V.G., et al (2017). Carcinoma of Unknown Primary Presenting as Peripheral Symmetric Gangrene. J Assoc Phys India, 65(2), 78-81.
39. Barwad, A., Phulware, R. H., Narwal, A., Gupta, V.G., & Ramteke, P. (2019). Not All the Spindle Cell Tumors in Oral Cavity Are Sarcomatoid Squamous Cell Carcinoma. Indian Journal of Surgical Oncology. doi: 10.1007/s13193-019-00991-w
40. Abbas, W., Goel, V., Verma, A., Gupta, V. G., & Rao, R. R. (2019). Harnessing the Immunomodulatory Effects of Radiation in Urinary Bladder Cancer. Cureus. doi:10.7759/cureus.4108
41. Naik, R. D., Kumar, L., Mittal, A., Gupta, V. G., et al. (2018). Outcome of multiple myeloma patients with renal failure: A retrospective study [Abstract]. Journal of Clinical Oncology, 36(15_suppl). doi:10.1200/JCO.2018.36.15_suppl.e20026
42. Oh, D.-Y., He, A. R., Bouattour, M., Okusaka, T., … Gupta V.G., … Valle, J. W. (2024). Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/S2468-1253(24)00095-5
43. Doddihal, H., Marron, T., C T, S., Avaronnan, M., Nagarkar, R., Gupta, V. G., et al  (2023). Pb2258: Phase 1 first in human study evaluating the safety, tolerability, pharmacokinetics and efficacy of grc54276, a novel hpk1 thronine-kinase inhibitor, in advanced solid tumours and lymphomas. HemaSphere, 7(S3), e56696bb.
44. Bouattour, M., Valle, J. W., Vogel, A., Kim, J. W., Kitano, M., Chen, J.-S., Burris Iii, H. A., Zaucha, R., Qin, S., Evesque, L., Zhen, D. B., Gupta, V. G., et al. (2023). Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer. Journal of Clinical Oncology, 41(4_suppl), 531–531.
45. Bharde, A., Shafi, G., Dongare, M., Jadhav, V. L. B., Khutale, G., Andhari, S., Prajapati, S., Jadhav, B., Mobeen, F., Hariramani, K., Basavalingegowda, M., Deshpande, R., Zhou, W., Uttarwar, M., Patel, K. B., Kishore, S., Singhal, M. K., Gupta, V. G., Thirumalairaj, R., & Khandare, J. (2024). Examination of genomic profile of true single circulating tumor cells (Sctc) from hepatocellular carcinoma and its effect on mutational features. Journal of Clinical Oncology, 42(16_suppl), e15039–e15039. https://doi.org/10.1200/JCO.2024.42.16_suppl.e15039
46. Patel, A., Akhade, A., Parikh, P., Sharma, A., Malhotra, H., Prabhash, K., Babu, G., Noronha, V., Batra, U., Mehta, P., Gupta, V. G., Radhakrishnan, V., Boya, R. R., & Biswas, B. (2022). Pembrolizumab weight based dosing – A call for policy change. Indian Journal of Medical and Paediatric Oncology, s-0042-1742651. https://doi.org/10.1055/s-0042-1742651
47. Mehta, P., Parikh, P., Aggarwal, S., Batra, A., Patel, A., Kulkarni, P., Sahoo, R., Gupta, V.G., et al, (2020). Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2. Indian Journal of Medical Sciences, 72, pp.8-12
48. Patel, A., Batra, A., Mehta, P., Sharma, A., Sirohi, B., Biswas, B., Gangulay, S., & Gupta, V.G. (2020). Gallbladder cancer: Adjuvant and palliative treatment during Covid-19 pandemic in India. Indian Journal of Medical and Paediatric Oncology
49. Bhethanabhotla, S., Pramanik, R., Srivastava, P., Mehta, P., Patel, A., Biswas, B., Batra, A., Gupta, V., Das, C., & Mahindru, S. (2020). Colorectal cancer chemotherapy during COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology
50. Pramanik, R., Srivastava, P., Sharma, A., Mehta, P., Patel, A., Bhethanbhotla, S., Biswas, B., Batra, A., Gupta, V., Das, C., & Mahendru, S. (2020). Management of head-and-neck cancer during COVID-19 crisis: A medical oncology perspective. Indian Journal of Medical and Paediatric Oncology
51. Das, C., Mahindru, S., Patel, A., Batra, A., Biswas, B., Mehta, P., Pramanik, R., Bhethanabhotla, S., & Gupta, V. (2020). How I treat epithelial ovarian cancer during COVID-19 pandemic. Indian Journal of Medical and Paediatric Oncology
52. Biswas, B., Ganguly, S., Dabkara, D., Ghosh, J., Srivastava, P., Mehta, P., Patel, A., Bhethanabhotla, S., Batra, A., Pramanik, R., Gupta, V., Das, C., & Mahindru, S. (2020). How we treat lung cancer during sars-Cov-2 (COVID-19) pandemic in India? Indian Journal of Medical and Paediatric Oncology

Government-funded extramural research

The Department of Science and Technology, Government of India has funded a project: “Lymphocyte Reconstitution and Infectious Morbidity Post Autologous Hematopoietic Stem Cell Transplantation” under Dr Ranjit Sahoo (Department of Medical Oncology, AIIMS New Delhi) which is currently in progress.

Membership of Professional Societies

• American Society of Clinical Oncology (ASCO)
• European Society for Medical Oncology (ESMO)
• International Society of Pediatric Oncology (SIOP)
• Indian Society of Medical and Pediatric Oncology (ISMPO)
• Pediatric Hemato-Oncology chapter, Indian Academy of Pediatrics (PHO-IAP)
• The AIIMSONIANS – Alumni association of the All India Institute of Medical Sciences, New Delhi

Educational activities

Dr Gupta has participated in innumerable teaching activities throughout his career and frequently participates in seminars and conferences for mutual education and learning.

Contact me for a free E-consultation

If you have a query related to cancer, You can also use the E-consultation form below to send it to me. You can send it to me at vineetgovindagupta@gmail.com.

Terms of Use